Form 8-K - Current report:
SEC Accession No. 0001193125-25-137478
Filing Date
2025-06-09
Accepted
2025-06-09 08:40:50
Documents
15
Period of Report
2025-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d94141d8k.htm   iXBRL 8-K 39111
2 EX-10.1 d94141dex101.htm EX-10.1 231036
3 EX-99.1 d94141dex991.htm EX-99.1 10366
7 GRAPHIC g94141g0608215053727.jpg GRAPHIC 4559
  Complete submission text file 0001193125-25-137478.txt   467819

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrvi-20250608.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrvi-20250608_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrvi-20250608_pre.xml EX-101.PRE 11261
17 EXTRACTED XBRL INSTANCE DOCUMENT d94141d8k_htm.xml XML 3656
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 251032918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)